13F Filings History of Eleva Capital SAS

13F snapshot Latest parsed holdings, value, and filing-period context. 1 signal
Form 13F summary
  • Eleva Capital SAS Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
  • Form 13F is generally due within 45 days after each calendar quarter ends.
  • Eleva Capital SAS reported 24 equity holdings with a total reported market value of $343,412,320 for Q2 2026. Top reported holdings included CRH, AS, NVDA, NFLX, and GOOGL.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
Yahya Muhieddine - analyst
Manager location
Paris, France

Follow Filing Activity

Follow Eleva Capital SAS with Pro and return when a new 13F portfolio filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Holdings Value

Form 13F evidence

Quarterly portfolio filings

SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.

Latest quarter
Q2 2026
Latest value
$343,412,320
Quarter delta
+$54,990
Accepted
02 Jul 2026, 11:05
Rows shown
1-4 of 4
Quarter Holdings SEC-reported value Bought Sold Net Top Holdings Form Type Accepted by SEC
Q2 2026 24 $343,412,320 $0 $0 $0 CRH, AS, NVDA, NFLX, GOOGL 13F-HR 02 Jul 2026, 11:05
Q1 2026 24 $343,357,330 +$56,334,239 -$46,595,027 +$9,739,212 CRH, AS, NVDA, NFLX, GOOGL 13F-HR 15 Apr 2026, 09:39
Q3 2025 15 $378,834,530 +$33,949,163 -$196,658,527 -$162,709,364 CRH, MELI, ANET, AS, MSFT 13F-HR 10 Nov 2025, 12:07
Q2 2025 33 $463,699,204 $0 $0 $0 CRH, FLUT, MSFT, NVDA, TSM 13F-HR 05 Aug 2025, 09:59
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .